You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 8, August 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Pediatrics, Other
 •Psychiatry
 •Child Psychiatry
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prescribing More Psychotropic Medications for Children

What Does the Increase Mean?

Arch Pediatr Adolesc Med. 2004;158:829-830.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The 1990s may become known as the decade of psychotropic medication use in children. This includes, to differing degrees, several classes of drugs: stimulants, antidepressants (especially selective serotonin reuptake inhibitors [SSRIs]), antianxiety agents, and antipsychotics. Evidence of increasing use among children of various ages has been mounting for years. Previous studies have demonstrated higher rates of psychoactive prescription use in adolescents,1 preschoolers,2 and those in between.3 These medications have been prescribed for attention-deficit/hyperactivity disorder (ADHD), conduct disorder, depression, and various other behavioral, mental, or learning disorders.

The article by Cooper et al4 contributes to this accumulating evidence by examining the changes in prescription rates of one class of medications given to children and adolescents (aged 2 to 18 years) in a large specific population (TennCare). The authors focus on new users of atypical antipsychotics in the Tennessee Medicaid population. By new users (perhaps better termed new uses), they designate . . . [Full Text of this Article]

Peter Conrad, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

New Users of Antipsychotic Medications Among Children Enrolled in TennCare
William O. Cooper, Gerald B. Hickson, Catherine Fuchs, Patrick G. Arbogast, and Wayne A. Ray
Arch Pediatr Adolesc Med. 2004;158(8):753-759.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Making All the Children Above Average: Ethical and Regulatory Concerns for Pediatricians in Pediatric Enhancement Research
Berg et al.
CLIN PEDIATR 2009;48:472-480.
ABSTRACT  

Psychotropic Medication Use in Pediatric Patients With Cancer
Pao et al.
Arch Pediatr Adolesc Med 2006;160:818-822.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.